scispace - formally typeset
S

Shahzaib Ahmad

Publications -  15
Citations -  58

Shahzaib Ahmad is an academic researcher. The author has contributed to research in topics: Medicine & Disease. The author has an hindex of 5, co-authored 15 publications receiving 58 citations.

Papers
More filters
Journal ArticleDOI

Targeting Oxidative Stress Mechanisms to Treat Alzheimer's and Parkinson's Disease: A Critical Review

TL;DR: To better understand how oxidative stress contributes to neurodegenerative diseases (such as Alzheimer's and Parkinson's), the medicinal qualities of medicines that target markers in the cellular oxidative pathways are analyzed.
Journal ArticleDOI

Lipid Lowering Therapy: An Era Beyond Statins.

TL;DR: A review of non-statin lipid-lowering therapies can be found in this paper , where the authors examined recent advances and emerging research, including gene-based therapy, small interfering RNAs, Antisense oligonucleotides, Adeno-associated virus vectors, CRISPR/Cas9 based therapeutics, and non-coding RNA therapy.
Journal ArticleDOI

Seven classes of antiviral agents

TL;DR: In this paper , the authors reviewed seven classes of antiviral agents: neutralizing antibodies, neutralizing recombinant soluble human receptors, antiviral CRISPR/Cas systems, interferons and small molecules.
Journal ArticleDOI

OMICs Technologies for Natural Compounds-based Drug Development.

TL;DR: This review summarizes technologies that are effective in natural source drug discovery and aid in a more precisely targeted pharmaceutical approach, including RNA interference or CRISPR technology.
Journal ArticleDOI

COVID-19, bubonic and meningitis in Democratic Republic of Congo: the confluence of three plagues at a challenging time

TL;DR: The Democratic Republic of Congo has been recorded as one of the povertystricken countries globally, with over 70% of the individuals living in poverty, and COVID19 has worsened this situation further as the majority lost their jobs, and the healthcare system capacity struggles to mitigate the impact of the ongoing pandemic.